Hikma confirms that it has not signed a licensing agreement with Opiant Pharmaceuticals

Retrieved on: 2022-04-30 05:34:03

Tags for this article:

Click the tags to see associated articles and topics

Hikma confirms that it has not signed a licensing agreement with Opiant Pharmaceuticals. View article details on hiswai:

Excerpt

We are a leading licensing partner, and through our venture capital arm, are helping bring innovative health technologies to people around the ...

Article found on: www.prnewswire.com